Trending Ticker: VIR Surges as Coronavirus fears persist [Yahoo! Finance News]
Vir Biotechnology, Inc. (VIR)
Company Research
Source: Yahoo! Finance News
Trending Ticker: VIR Surges as Coronavirus fears persist Yahoo Video February 27, 2020 As the markets continue to fall, the biotech field is seeing a boost as companies race to develop vaccines and a cure. Vir Biotechnology Inc. shares surged over 60%, while Gilead Sciences stocks saw a bump of 4%. Yahoo 's Alexis Christoforous and Brian Sozzi break it down on The First Trade.
Show less
Read more
Impact Snapshot
Event Time:
VIR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VIR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VIR alerts
High impacting Vir Biotechnology, Inc. news events
Weekly update
A roundup of the hottest topics
VIR
News
- Vir Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Vir Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceBusiness Wire
- Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA PRIME Designation for Tobevibart and Elebsiran in Chronic Hepatitis DeltaBusiness Wire
- Vir Biotechnology to Host Virtual Investor Event on PRO-XTEN™ Masked T-Cell Engager Programs [Yahoo! Finance]Yahoo! Finance
- Vir Biotechnology to Host Virtual Investor Event on PRO-XTEN™ Masked T-Cell Engager ProgramsBusiness Wire
VIR
Earnings
- 10/31/24 - Miss
VIR
Sec Filings
- 12/4/24 - Form 4
- 12/2/24 - Form 144
- 11/18/24 - Form 4
- VIR's page on the SEC website